Diabetes Fear of Injecting and Self-Testing Questionnaire

a psychometric evaluation

E D Mollema, Frank J Snoek, F Pouwer, R. J. Heine, Henk M Van Der Ploeg

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

OBJECTIVE: To study the psychometric properties of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ).

RESEARCH DESIGN AND METHODS: Two groups of patients were studied. Sample A consisted of 252 insulin-treated diabetes patients. Sample B incorporated 24 insulin-treated patients with high scores (> or = 95th percentile) on the D-FISQ. Test-retest correlations were assessed in both samples. Discriminant and convergent validity of the D-FISQ were assessed with questionnaires concerning fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death. To evaluate criterion-related validity, sample B participated in a behavioral avoidance test (BAT), in which the current level of avoidance of either self-injecting or self-testing was determined. Exploratory factor analysis (EFA) was performed to study whether 2 factors (fear of self-injecting [FSI] and fear of self-testing [FST]) could be detected.

RESULTS: Test-retest correlations ranged from 0.50 to 0.68 (P < 0.001). Correlations between D-FISQ and fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death ranged from 0.28 to 0.45 (P < 0.001). Patients who refused to do a BAT for self-injecting or self-testing had higher scores on FSI (P = 0.095) and FST (P = 0.01). EFA yielded 2 separate factors, FSI and FST.

CONCLUSIONS: Results from this study support reliability and validity of the D-FISQ, a self-report instrument that can be used for both clinical and research purposes.

OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind23
Udgave nummer6
Sider (fra-til)765-9
Antal sider5
ISSN0149-5992
StatusUdgivet - jun. 2000

Fingeraftryk

Psychometrics
Surveys and Questionnaires
Hypoglycemia
Statistical Factor Analysis
Insulin
Wounds and Injuries
Reproducibility of Results
Self Report
Research Design

Citer dette

Mollema, E. D., Snoek, F. J., Pouwer, F., Heine, R. J., & Van Der Ploeg, H. M. (2000). Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care, 23(6), 765-9.
Mollema, E D ; Snoek, Frank J ; Pouwer, F ; Heine, R. J. ; Van Der Ploeg, Henk M. / Diabetes Fear of Injecting and Self-Testing Questionnaire : a psychometric evaluation. I: Diabetes Care. 2000 ; Bind 23, Nr. 6. s. 765-9.
@article{6ff45a919c624b379627dcfdb496b7b3,
title = "Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation",
abstract = "OBJECTIVE: To study the psychometric properties of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ).RESEARCH DESIGN AND METHODS: Two groups of patients were studied. Sample A consisted of 252 insulin-treated diabetes patients. Sample B incorporated 24 insulin-treated patients with high scores (> or = 95th percentile) on the D-FISQ. Test-retest correlations were assessed in both samples. Discriminant and convergent validity of the D-FISQ were assessed with questionnaires concerning fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death. To evaluate criterion-related validity, sample B participated in a behavioral avoidance test (BAT), in which the current level of avoidance of either self-injecting or self-testing was determined. Exploratory factor analysis (EFA) was performed to study whether 2 factors (fear of self-injecting [FSI] and fear of self-testing [FST]) could be detected.RESULTS: Test-retest correlations ranged from 0.50 to 0.68 (P < 0.001). Correlations between D-FISQ and fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death ranged from 0.28 to 0.45 (P < 0.001). Patients who refused to do a BAT for self-injecting or self-testing had higher scores on FSI (P = 0.095) and FST (P = 0.01). EFA yielded 2 separate factors, FSI and FST.CONCLUSIONS: Results from this study support reliability and validity of the D-FISQ, a self-report instrument that can be used for both clinical and research purposes.",
keywords = "Adult, Anxiety, Attitude to Death, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1, Exploratory Behavior, Fear, Female, Humans, Hypoglycemia, Injections, Intravenous, Insulin, Male, Middle Aged, Psychometrics, Reproducibility of Results, Self-Assessment, Surveys and Questionnaires, Journal Article, Research Support, Non-U.S. Gov't",
author = "Mollema, {E D} and Snoek, {Frank J} and F Pouwer and Heine, {R. J.} and {Van Der Ploeg}, {Henk M}",
year = "2000",
month = "6",
language = "English",
volume = "23",
pages = "765--9",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "6",

}

Mollema, ED, Snoek, FJ, Pouwer, F, Heine, RJ & Van Der Ploeg, HM 2000, 'Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation', Diabetes Care, bind 23, nr. 6, s. 765-9.

Diabetes Fear of Injecting and Self-Testing Questionnaire : a psychometric evaluation. / Mollema, E D; Snoek, Frank J; Pouwer, F; Heine, R. J.; Van Der Ploeg, Henk M.

I: Diabetes Care, Bind 23, Nr. 6, 06.2000, s. 765-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Diabetes Fear of Injecting and Self-Testing Questionnaire

T2 - a psychometric evaluation

AU - Mollema, E D

AU - Snoek, Frank J

AU - Pouwer, F

AU - Heine, R. J.

AU - Van Der Ploeg, Henk M

PY - 2000/6

Y1 - 2000/6

N2 - OBJECTIVE: To study the psychometric properties of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ).RESEARCH DESIGN AND METHODS: Two groups of patients were studied. Sample A consisted of 252 insulin-treated diabetes patients. Sample B incorporated 24 insulin-treated patients with high scores (> or = 95th percentile) on the D-FISQ. Test-retest correlations were assessed in both samples. Discriminant and convergent validity of the D-FISQ were assessed with questionnaires concerning fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death. To evaluate criterion-related validity, sample B participated in a behavioral avoidance test (BAT), in which the current level of avoidance of either self-injecting or self-testing was determined. Exploratory factor analysis (EFA) was performed to study whether 2 factors (fear of self-injecting [FSI] and fear of self-testing [FST]) could be detected.RESULTS: Test-retest correlations ranged from 0.50 to 0.68 (P < 0.001). Correlations between D-FISQ and fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death ranged from 0.28 to 0.45 (P < 0.001). Patients who refused to do a BAT for self-injecting or self-testing had higher scores on FSI (P = 0.095) and FST (P = 0.01). EFA yielded 2 separate factors, FSI and FST.CONCLUSIONS: Results from this study support reliability and validity of the D-FISQ, a self-report instrument that can be used for both clinical and research purposes.

AB - OBJECTIVE: To study the psychometric properties of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ).RESEARCH DESIGN AND METHODS: Two groups of patients were studied. Sample A consisted of 252 insulin-treated diabetes patients. Sample B incorporated 24 insulin-treated patients with high scores (> or = 95th percentile) on the D-FISQ. Test-retest correlations were assessed in both samples. Discriminant and convergent validity of the D-FISQ were assessed with questionnaires concerning fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death. To evaluate criterion-related validity, sample B participated in a behavioral avoidance test (BAT), in which the current level of avoidance of either self-injecting or self-testing was determined. Exploratory factor analysis (EFA) was performed to study whether 2 factors (fear of self-injecting [FSI] and fear of self-testing [FST]) could be detected.RESULTS: Test-retest correlations ranged from 0.50 to 0.68 (P < 0.001). Correlations between D-FISQ and fear of hypoglycemia, trait anxiety, and fear of bodily injury, illness, or death ranged from 0.28 to 0.45 (P < 0.001). Patients who refused to do a BAT for self-injecting or self-testing had higher scores on FSI (P = 0.095) and FST (P = 0.01). EFA yielded 2 separate factors, FSI and FST.CONCLUSIONS: Results from this study support reliability and validity of the D-FISQ, a self-report instrument that can be used for both clinical and research purposes.

KW - Adult

KW - Anxiety

KW - Attitude to Death

KW - Blood Glucose Self-Monitoring

KW - Diabetes Mellitus, Type 1

KW - Exploratory Behavior

KW - Fear

KW - Female

KW - Humans

KW - Hypoglycemia

KW - Injections, Intravenous

KW - Insulin

KW - Male

KW - Middle Aged

KW - Psychometrics

KW - Reproducibility of Results

KW - Self-Assessment

KW - Surveys and Questionnaires

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

M3 - Journal article

VL - 23

SP - 765

EP - 769

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 6

ER -

Mollema ED, Snoek FJ, Pouwer F, Heine RJ, Van Der Ploeg HM. Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care. 2000 jun;23(6):765-9.